Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors

J Immunol. 1996 Feb 1;156(3):1117-25.

Abstract

This study investigated the generation of primary tumor-specific CTL activity in vitro to several mouse tumors. We report that the development of optimal primary tumor-specific CTL to the P815 mastocytoma, the EL4 thymoma, and the Lewis lung carcinoma is dependent on tumor Ags, on enhancement of T cell costimulation by B7.1, and on exogenous T helper activity in the form of IL-2 and IL-4. A relatively low concentration of IL-2 and IL-4 was required to limit the induction of lymphokine-activated killer cells. In the case of P815, the CTL were directed toward molecularly defined tumor rejection Ags. These primary cultures yielded long term T cell lines that were heterogeneous in fine tumor Ag specificity and in cytokine production.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, Neoplasm / pharmacology
  • B7-1 Antigen / pharmacology
  • Carcinoma, Lewis Lung / metabolism
  • Cytotoxicity, Immunologic*
  • Growth Inhibitors / metabolism
  • Immunophenotyping
  • Interleukin-2 / immunology
  • Lymphocyte Activation
  • Mast-Cell Sarcoma / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / transplantation
  • Tumor Cells, Cultured

Substances

  • Antigens, Neoplasm
  • B7-1 Antigen
  • Growth Inhibitors
  • Interleukin-2